Latest News

TREE: SelectUSA-awarded Taiwan startups met Bay Area founders and investors

SAN FRANCISCO, July 4, 2022 /PRNewswire/ -- July 4th is the time to be proud to be Americans, and sixTaiwan startups were invited by SelectUSA Investment Summit to consider investing in the U.S. Followed by the summit, they are visiting the Bay Area during the Independent Day weekend to exchange ...

2022-07-05 11:23 2442

QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event

Event focuses on real-world use cases for new technologies, including quantum, poised to improve health and the life sciences TOKYO, July 4, 2022 /PRNewswire/ -- QunaSys, a global leader in the development of innovative quantum algorithms in chemistry and a Pistoia Alliance member company, will ...

2022-07-05 10:00 2555

ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities

PHILADELPHIA, July 4, 2022 /PRNewswire/ -- Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly A...

2022-07-05 09:20 3198

WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products

* WuXi Biologics expands its extensive integrated CRDMO services by offering development and cGMP manufacturing for microbial-derived products. HANGZHOU, China, July 4, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing ...

2022-07-05 08:30 3335

Allschool Champions the Power of Choice with "Celebrate Independence Day" Themed Classes

Pursuing Happiness in Children's Dreams of Independence SAN MATEO, Calif., July 4, 2022 /PRNewswire/ -- Leading provider of online interactive classes,Allschool, launched "Celebrate Independence Day

2022-07-05 00:05 2868

Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia

This is the first clinical trial approved in China for presbyopia drugs and Arctic Vision's study marks the first patient enrollment in a Phase III clinical trial for presbyopia drugs inChina. ARVN003 is expected to be the first approved drug for presbyopia inChina. SHANGHAI, July 4, 2022 /PRNew...

2022-07-04 22:14 3248

Magic Data Paper is Accepted by INTERSPEECH 2022

BEIJING, July 4, 2022 /PRNewswire/ -- Magic Data's paper 'Open Source MagicData-RAMC: A Rich Annotated Mandarin Conversational(RAMC) Speech Dataset' is accepted by INTERSPEECH 2022, the world's largest and most comprehensive conference on the science and technology of spoken language processing....

2022-07-04 22:04 3231

"Captain Tsubasa: Dream Team" Dream Championship 2022 Worldwide Tournament Begins in September & the Official Website Opens Today

TOKYO, July 4, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Teamwill hold the worldwide Dream Championship 2022 tournament starting Friday, September 9th. Additionally, the official website ( https:...

2022-07-04 19:15 3538

FX168 Financial Group to hold the Vancouver International Financial Summit (VIFS) 2022 on September 2 to 3

VANCOUVER, BC, July 4, 2022 /PRNewswire/ -- In the face of many fears from the market due to accelerating inflation, recessionary concerns, etc., FX168 Financial Group invited elites and experts in the industry in various economics and investment fields to hold the Vancouver International Financi...

2022-07-04 17:09 2695

SmartX Releases CloudTower 2.0: Enhances Simplicity and Security for Operations & Maintenance

BEIJING, July 4, 2022 /PRNewswire/ -- SmartX  has released CloudTower 2.0, a central management platform for multiple clusters across data centers. CloudTower is a crucial member of theSmartX HCI  product portfolio, provid...

2022-07-04 17:04 2649

Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061

SHANGHAI, July 4, 2022 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (HKEX Stock Code: 2256.HK, referred to "Abbisko Therapeutics" hereafter) today announced completion of dosing of the first patient in the Phase 1 clinical trial in advanced solid tumors for ABSK061, which becomes the first high...

2022-07-04 13:34 3185

ProScreenCast Launches 4K 60Hz HDR Screen Casting Adaptor

NEW YORK, July 3, 2022 /PRNewswire/ -- ProScreenCast  has announced their newest 4K 60Hz with HDR screen casting adaptor, the SC01, is now available worldwide.SC01  build with HDMI2.0b and is c...

2022-07-04 11:04 3383

Global Times: Xi marks HKSAR's 25th anniversary, points clear future of city as 'no need to change a good system'

BEIJING, July 3, 2022 /PRNewswire/ -- A joyful and exciting sentiment was widely shared on Friday not only inHong Kong, despite the wind and rain, but also in the Chinese mainland and beyond the country on the occasion of the 25th anniversary of the city's return to the motherland.Hong Kong is em...

2022-07-03 15:20 3085

150 Scholarships to Empower Pathways to STEM & Sustainability Education in Australia

NEW YORK, July 2, 2022 /PRNewswire/ -- Empowering young people from diverse backgrounds across the globe is central to addressing global challenges like climate change. AFS Intercultural Programs, a global non-profit educational exchange organisation, is proud to launch a new scholarship program,...

2022-07-02 01:20 7553

Vanpowers Bike Launches Road E-bike City Vanture on Indiegogo over 270% Funded

BRIDGEWATER, N.J., July 1, 2022 /PRNewswire/ -- Vanpowers Bike, a specialist e-bike company, has just ended itscrowdfunding campaign forCity Vanture

2022-07-01 22:00 6641

ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer

SOUTH SAN FRANCISCO, Calif., July 1, 2022  /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment ofPaul August, Ph.D., as the Chief Scientific Officer. "We are thrilled to welcome Dr. August to our team," s...

2022-07-01 22:00 5702

Data Interconnection Achieved Between NEA and Xpeng, Charges Cars Faster and cheaper in China

WUXI, China, July 1, 2022 /PRNewswire/ -- The new energy automobile industry, featuring electric vehicles, is developing at a rapid pace inChina. As an important part of the industrial chain, charging piles has also entered the fast lane of growth. As the battery power and driving ranges are incr...

2022-07-01 21:30 5980

GBA Forum on Sci-Tech Innovation and Cooperation Held in Qianhai, Shenzhen

SHENZHEN, China, July 1, 2022 /PRNewswire/ -- Guangdong, Hong Kong, and Macao are entering a new era of fast growth in sci-tech innovation and cooperation. On June 30, Guangdong-Hong Kong-Macao Sci-Tech Innovation Cooperation Forum was held in Qianhai,Shenzhen. The forum aimed to promote the refor...

2022-07-01 20:52 5995

China's Largest Displacement and Horsepower Hydrogen-fueled Engine Yuchai YCK16H Successfully Ignited

YULIN, China, July 1, 2022 /PRNewswire/ -- On June 30, Yuchai YCK16H hydrogen-fueled engine was successfully ignited in Yulin,Guangxi. The engine, with a displacement of 15.93 liters and a maximum horsepower of 560 hp, is the largest hydrogen-fueled engine with the largest displacement and horsep...

2022-07-01 20:30 6307

Trip.com Group Announces Changes in Board Composition

SHANGHAI, July 1, 2022 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, today announced that Dr....

2022-07-01 18:00 6824